Viewing nowBast Tablet 20 Milligrams (Simvastatin)
Simvastatin 20mg
Tablet · Prescription medication
(Co., Ltd.) Hawon Pharmaceutical

MFDS item code 200402982 · Notified 2004.08.09 · Insurance code 651500560
Improvement of hyperlipidemia; improvement of familial hypercholesterolemia in children; prevention of cardiovascular disease
This medication helps reduce the risk of cardiovascular diseases. It decreases the risk of death due to heart diseases and the risk of non-fatal myocardial infarction and stroke in adult patients with a history of vascular-related diseases such as coronary heart disease, diabetes, peripheral vascular disease, and stroke. Additionally, it lowers the risks associated with coronary and non-coronary vascular interventions. For patients with hyperlipidemia, it improves total cholesterol, LDL-cholesterol, Apo-B protein, and triglyceride levels while increasing HDL-cholesterol, and is used as an adjunct in the treatment of various types of dyslipidemia. In particular, it helps manage cholesterol levels in children with familial hypercholesterolemia or other risk factors when used in conjunction with dietary therapy. Therefore, this medication is used for the treatment of cardiovascular diseases and hyperlipidemia.
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. The recommended dose is 5 ~ 40 mg of this medicine once daily in the evening. Adjust the dose as appropriate based on the initial LDL cholesterol level before treatment, the treatment target, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if the cholesterol level falls below the target level. Because of the increased risk of myopathy, including rhabdomyolysis, use of this medicine at a dose of 80 mg, particularly during the first year of treatment, is restricted to patients who have taken 80 mg of this medicine for 12 months or more without evidence of muscle toxicity (see Precautions for Use, 1. Warnings). 2) Refer to the information below for recommended doses in patients taking this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, or amlodipine, and in certain patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment) (see Precautions for Use, 6. Drug Interactions). (1) Use in patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, administer 40 mg of this medicine once daily in the evening to patients with homozygous familial hypercholesterolemia. Use this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when other lipid-lowering treatments are not available. (2) In elderly patients, the maximum cholesterol-lowering effect may be achieved with a daily dose of 20 mg of this medicine. (3) Use in patients taking verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Use in patients taking amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day. (5) Concomitant use with other lipid-lowering agents This medicine is effective when used alone or in combination with a bile acid sequestrant. When this medicine is coadministered with fibrates (excluding gemfibrozil (see Precautions for Use, 2. Patients Who Must Not Use This Medicine) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. (6) Use in patients with renal impairment As this medicine is not extensively excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg once daily and monitor carefully.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day; the recommended maximum dose is 40 mg per day.
This medication can cause muscle disorders such as myopathy or rhabdomyolysis, especially at high doses. Therefore, patients taking this medication at high doses should immediately consult a doctor if they experience muscle pain or weakness. Patients with an allergy to this medication, those with active liver disease, pregnant women or women of childbearing potential, and patients taking certain medications should not use this medication. Patients with impaired liver or kidney function, those with hypothyroidism, the elderly, and women should exercise additional caution when using this medication. This medication can affect liver function; therefore, regular liver function tests and blood tests are necessary, and if any symptoms of liver abnormalities appear, use should be discontinued immediately. As this medication interacts with other drugs, the risk of muscle damage may increase, especially when taken with certain antifungals, antibiotics, immunosuppressants, or some heart medications, so it is crucial to inform the doctor or pharmacist about all current medications. Grapefruit juice should be avoided as it may increase the blood concentration of this medication, raising the risk of side effects. Pregnant or breastfeeding women should not take this medication, and women who are of childbearing age should ensure adequate contraception while taking it. Children and adolescents can only use this medication beyond a certain age, so they must follow a doctor's instructions. In case of overdose, seek medical attention immediately for appropriate treatment, and this medication should be kept out of the reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to maintain a storage temperature between 1°C and 30°C at room temperature. Proper storage will help maintain the safety and effectiveness of the medication.
Brownish-yellow oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowSimvastatin 20mg
Tablet · Prescription medication
(Co., Ltd.) Hawon Pharmaceutical

Simvastatin 20mg
Tablet · Prescription medication
Jongkundang Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Dong-A ST Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Korea Hutech Pharmaceutical Co., Ltd.
Simvastatin 20mg
Tablet · Prescription medication
Yuhan Corporation

Simvastatin 40mg
Tablet · Prescription medication
Dongwha Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
Dongsung Pharmaceutical Co., Ltd.

Simvastatin 20mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.